What is Cymbalta?
Cymbalta, which has the generic name of duloxetine hydrochloride, is marketed by Eli Lilly and Company. Cymbalta is an antidepressant medication and is a member of the class of drugs known as serotonin and norepinephrine reuptake inhibitors, which are commonly referred to as SNRIs. This class of drugs is designed to work by increasing the activity of the chemicals in the brain known as serotonin and norepinephrine. Cymbalta is approved by the FDA for use in the treatment of depression and Cymbalta is also prescribed in the treatment of diabetic peripheral neuropathy, also referred to as DPNP. Cymbalta was initially approved by the FDA in 2003.
Cymbalta Black Box Warning
The FDA has recently ordered that all antidepressants, including Cymbalta, must add a "black box warning" to the labeling regarding a possible link to increased suicidal thoughts and behavior in children and adolescents. The black box warning is the strongest warning that the FDA has at its disposal. Data from 24 trials involving 4,400 patients indicated that approximately 2 to 3 percent of children and adolescents that take antidepressants have increased suicidal thoughts and actions. Children who are prescribed antidepressants should be monitored for signs of unusual changes in mood or behavior, and increased thoughts of suicide, especially when treatment begins and when the dosage of the medication is altered. Some reports have indicated that antidepressants may be linked to an increase in suicidal thoughts or behavior in adults as well. In a study of Cymbalta's effects on stress urinary incontinence, also referred to as SUI, in adult women, a greater number of patients than expected attempted suicide or indicated having suicidal thoughts.
 Contact us regarding Cymbalta; attorney consultations are free.
Cymbalta Linked to Liver Damage
Some recent reports have linked Cymbalta to incidents of liver damage. Cymbalta has been linked to reports of liver problems including hepatitis and cholestatic jaundice. Cymbalta patients should be mindful of the symptoms of liver damage, which may include, jaundice, dark urine, weakness, nausea, abdominal tenderness near the liver, and flu like symptoms. Patients with pre-existing liver problems may be at an increased risk of aggravating their condition and those patients who have substantial alcohol use or suffer from chronic liver disease are advised not to ordinarily be prescribed Cymbalta.
Questions and Consultations
If you or a family member has used the prescription drug Cymbalta and noticed adverse side effects, such as suicidal thoughts or liver problems, you should contact a physician immediately. If you would like to discuss your rights, are interested in more information on Cymbalta litigation, or if you have information about the cases that you would like to share with us, please fill out the short evaluation form below and a member of Seeger Weiss LLP's experienced staff will call you to discuss your potential rights concerning Cymbalta. Attorney consultations incur no obligation on your part and all initial consultations are free of charge and do not create an attorney-client relationship. Seeger Weiss LLP has office locations in both New York and New Jersey and its attorneys practice in courts throughout the country.
Link To Lawyer Seek's Cymbalta Content:
<a href='http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Cymbalta-P92/'>Cymbalta: Lawyer Seek</a> |
|
